Glucotrack, Inc.

For the period ended Jun 30, 2026. Filed Aug 14, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 14, 2026

GCTK$1.39-32.2%Stored close · as of Oct 29, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets

(in thousands of US dollars except share data)

	June 30, 2026	December 31, 2025
Unaudited
Current Assets
Cash and cash equivalents	$1,124	$7,383
Other current assets	257	284
Total current assets	1,381	7,667
Operating lease right-of-use asset, net	19	33
Property and equipment, net	95	138
TOTAL ASSETS	$1,495	$7,838
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
Current Liabilities
Accounts payable	$1,116	$1,317
Operating lease liability, current	19	28
Promissory notes	1,692	3,182
Other current liabilities	161	246
Total current liabilities	2,988	4,773
Non-Current Liabilities
Derivative financial liabilities	-	1
Operating lease liability, non-current	-	5
Loans from stockholders	248	231
Total liabilities	3,236	5,010
Commitments and contingent liabilities (Note 4)	-
Stockholders’ Equity (Deficit)
Common Stock of $0.001 par value (“Common Stock”):
250,000,000 shares authorized as of June 30, 2026 and as of December 31, 2025; 6,259,279 and 910,688 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively	6	1
Additional paid-in capital	158,187	151,080
Receipts on account of shares	-	3,544
Accumulated other comprehensive income	52	41
Accumulated deficit	(159,986)	(151,838)
Total stockholders’ equity (deficit)	(1,741)	2,828
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)	$1,495	$7,838

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.